Modern Treatment of Androgenetic Alopecia

    August 2026 in “ Orvosi Hetilap ”
    Petra Rózsa, Lajos Kemény, Rolland Gyulai
    Studysummary In this study, researchers reported that while conventional treatments like topical minoxidil remain fundamental for androgenetic alopecia, guidelines increasingly support low-dose oral minoxidil and dutasteride, though their recommendations vary. Personalized multimodal treatment strategies and regular follow-ups are essential in clinical practice.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on akjournals.com →
    Discuss this study in the Community →

    Research cited in this study 27

    1. Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment Brain Sciences · 2026
    2. Expanding the Therapeutic Landscape of Minoxidil for Androgenetic Alopecia: Topical, Oral and Sublingual Formulations Frontiers in Pharmacology · 2026
    3. A Canadian Consensus on Androgenetic Alopecia: Approach and Management Journal of Cutaneous Medicine and Surgery · 2025
    4. Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System International Journal of Dermatology · 2025
    5. Multidimensional Assessment of Adverse Events of Finasteride: A Real-World Pharmacovigilance Analysis Based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024 PLoS ONE · 2025
    6. Evaluating the Efficacy and Safety of Combined Microneedling Therapy Versus Topical Minoxidil in Androgenetic Alopecia: A Systematic Review and Meta-Analysis Archives of Dermatological Research · 2025
    7. Immune and Non-Immune Interactions in the Pathogenesis of Androgenetic Alopecia Clinical Reviews in Allergy & Immunology · 2025
    8. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss JAMA Dermatology · 2024
    9. Oral Minoxidil Versus Topical Minoxidil for Male Androgenetic Alopecia JAMA dermatology · 2024
    10. Guidelines of Care for the Management of Acne Vulgaris Journal of the American Academy of Dermatology · 2024
    11. Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Document from the Spanish Trichology Group of the Spanish Academy of Dermatology and Venereology Actas Dermo-Sifiliográficas · 2023
    12. The Post-Finasteride Syndrome: Possible Etiological Mechanisms and Symptoms International journal of impotence research · 2023
    13. Psychosocial Impact of Androgenetic Alopecia on Men: A Systematic Review and Meta-Analysis Psychology, Health & Medicine · 2023
    14. Global Online Interest in Finasteride Sexual Side Effects International Journal of Impotence Research · 2022
    15. Efficacy and Safety of Topical Finasteride Spray Solution for Male Androgenetic Alopecia: A Phase III, Randomized, Controlled Clinical Trial Journal of The European Academy of Dermatology and Venereology · 2021
    16. Risk of Depression Associated with Finasteride Treatment Journal of Clinical Psychopharmacology · 2021
    17. Androgenetic Alopecia in Women and Men: Italian Guidelines Adapted from European Dermatology Forum/European Academy of Dermatology and Venereology Guidelines Giornale italiano di dermatologia e venereologia · 2020
    18. Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride JAMA Dermatology · 2020
    19. Platelet-Rich Plasma for Androgenetic Alopecia: A Review of the Literature and Proposed Treatment Protocol International Journal of Women's Dermatology · 2018
    20. Guidelines for the Diagnosis and Treatment of Male-Pattern and Female-Pattern Hair Loss, 2017 Version Journal of Dermatology · 2018
    21. Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version Journal of The European Academy of Dermatology and Venereology · 2017
    22. Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss The Journal of Clinical Endocrinology and Metabolism · 2016
    23. The Female Pattern Hair Loss: Review of Etiopathogenesis and Diagnosis BioMed Research International · 2014
    24. Human Hair Follicles Contain Two Forms of ATP-Sensitive Potassium Channels, Only One Sensitive to Minoxidil The FASEB Journal · 2008
    25. Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for Their Modes of Action in Hair Follicles Journal of Investigative Dermatology · 2005
    26. Minoxidil-Induced Hair Growth Is Mediated by Adenosine in Cultured Dermal Papilla Cells: Possible Involvement of Sulfonylurea Receptor 2B as a Target of Minoxidil Journal of Investigative Dermatology · 2001
    27. Topical Minoxidil for Hair Growth in Alopecia Areata and Androgenetica Drugs · 1987